Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety… Grant US-11752155-B2 United States of America 12 Sep 2023
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists Grant US-11136328-B2 United States of America 05 Oct 2021
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety… Grant US-11000526-B2 United States of America 11 May 2021
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists Grant US-10584127-B2 United States of America 10 Mar 2020
Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists Grant US-10420768-B2 United States of America 24 Sep 2019
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists Grant US-10294230-B2 United States of America 21 May 2019
3,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists Grant US-10221182-B2 United States of America 05 Mar 2019
Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists Grant US-10030026-B2 United States of America 24 Jul 2018
Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists Grant US-9968610-B2 United States of America 15 May 2018
GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS Application WO-2017085215-A1 World Intellectual Property Organisation (WIPO) 26 May 2017